Drugs Made In America Acquisition cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 3 quarters of results from Sep 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -0.05M | 4.59M | 4.40M |
| Cash from Operations | -0.69M | -0.31M | |
| Change in Working Capital | |||
| Change in Account Payables | 0.00M | 0.09M | |
| Change in Accured Expenses | 0.08M | ||
| Misc. | |||
| Change in Cash | 0.31M | -0.31M | |
| Free Cash Flow | -0.69M | -0.31M | |
| Net Cash Flow | -0.69M | -0.31M |